| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +546% |
| 3Y CAGR | +2,345% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +524% |
| 3Y CAGR | +155% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹19,674.00 +250.00 (1.29%) | 24,935.15 | 50.09 | 13.31 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,414.70 +50.10 (2.12%) | 17,953.96 | 26.48 | 5.33 | ||
PfizerPFIZER | ₹3,854.50 +32.90 (0.86%) | 17,370.41 | 23.63 | 4.13 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,358.50 +13.50 (0.21%) | 15,851.50 | 93.45 | 18.16 |